Yongsheng Li

41PUBLICATIONS
65CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 09, 2026
Applications of Mesenchymal Stromal Cells for Treatment of Diseases.

|Aug 23, 2026
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

|Jul 24, 2026
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study.

|Jul 10, 2026
MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation.

|May 21, 2026
Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer.

|Mar 04, 2026
Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study.

Huaqiang Zhou, Hongyun Zhao, Xue Hou

Pageof 7

Frequent Collaborators

4 joint publications

Lei Wu

3 joint publications

Wenfeng Fang

3 joint publications

Hongyun Zhao

3 joint publications

Li Zhang